Paul Tudor Jones Fusion Pharmaceuticals Inc. Transaction History
Tudor Investment Corp Et Al
- $15.5 Billion
- Q1 2024
A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Fusion Pharmaceuticals Inc. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 32,919 shares of FUSN stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
32,919Holding current value
$0% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding FUSN
# of Institutions
142Shares Held
67.3MCall Options Held
1.36MPut Options Held
3.97M-
Federated Hermes, Inc. Pittsburgh, PA10.8MShares$00.54% of portfolio
-
Perceptive Advisors LLC New York, NY6.83MShares$03.05% of portfolio
-
Avidity Partners Management LP Dallas, TX6.5MShares$05.35% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY6.4MShares$02.82% of portfolio
-
Fil LTD Hamilton, D04.19MShares$00.09% of portfolio
About Fusion Pharmaceuticals Inc.
- Ticker FUSN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,390,500
- Description
- Fusion Pharmaceuticals Inc., a clinical-stage oncology company, focuses on developing radiopharmaceuticals as precision medicines. The company has developed Targeted Alpha Therapies platform together with its proprietary Fast-Clear linker technology to enable us to connect alpha particle emitting isotopes to various targeting molecules in order ...